InvestSMART

Nuchev Limited (ASX: NUC) - Share Price

- Current share price for NUC : $0.080

Nuchev Limited (NUC) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a Company that is engaged in development, marketing and selling of Australian made Nutritional and Vitamin and Dietary Supplement products.

NUC General Information +

ASX Code NUC
Website http://www.nuchev.com.au
Industry/Sector Packaged Foods & Meats
Market Cap ($M) 12
NUC Share Price $0.080
Day High $0.080
Day Low $0.080
Last Close $0.080
NUC Share Price Movement - ( No change )
Prices as at 16:40, 30 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Nuchev Limited (NUC) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Nuchev Limited (NUC) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Nuchev Limited (NUC) price-sensitive announcements

NUC - Appendix 4C and Quarterly Activities Report
Nuchev Limited’s Quarterly Activities Report and Appendix 4C for the quarter ended 30 Sept
Nuchev Limited (NUC)
30 Oct 2026 | 9:32 AM
NUC - Nouvlait Arbitration- Final Award
Nuchev Limited announced that the Shanghai Arbitration Commission issued a final award dat
Nuchev Limited (NUC)
10 Sep 2026 | 9:58 AM
NUC - Nuchev Expands into Womens Health
Nuchev Limited (ASX: NUC) announced on 28 August 2026 that it has entered into an exclusiv
Nuchev Limited (NUC)
28 Aug 2026 | 1:32 PM
NUC - FY26 Results Presentation
Nuchev Limited’s FY26 Full Year Results presentation for the year ended 30 June 2026 outli
Nuchev Limited (NUC)
27 Aug 2026 | 4:54 PM

Nuchev Limited (NUC) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Nuchev Limited (NUC)
ORDINARY FULLY PAID
 Consumer Staple $13 Appendix 4C and Quarterly Activities Report 30 Oct 2026 9:32AM $0.080 $0.080 fallen by 0%
Nuchev Limited (NUC)
ORDINARY FULLY PAID
 Consumer Staple $13 Notice of Annual General Meeting 23 Oct 2026 2:54PM $0.080 $0.080 fallen by 0%
Nuchev Limited (NUC)
ORDINARY FULLY PAID
 Consumer Staple $13 Nouvlait Arbitration- Final Award 10 Sep 2026 9:58AM $0.085 $0.080 fallen by 5.88%
Nuchev Limited (NUC)
ORDINARY FULLY PAID
 Consumer Staple $13 Date of AGM and Closing Date for Director Nominations 8 Sep 2026 3:10PM $0.085 $0.080 fallen by 5.88%
Nuchev Limited (NUC)
ORDINARY FULLY PAID
 Consumer Staple $13 Nuchev Expands into Womens Health 28 Aug 2026 1:32PM $0.090 $0.080 fallen by 11.11%
Nuchev Limited (NUC)
ORDINARY FULLY PAID
 Consumer Staple $13 Corporate Governance Statement and Appendix 4G 27 Aug 2026 4:59PM $0.090 $0.080 fallen by 11.11%

NUC Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$5.51 -$3.60 27.20% 0.00 0.00 0.00% 0.0%
2025A -$4.08 -$2.80 -61.80% 0.00 0.00 0.00% 0.0%
2024A -$6.25 -$7.30 -54.40% 0.00 0.00 0.00% 0.0%

NUC Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
The a2 Milk Company Limited (A2M) $4,951M -0.5230 0.9644 0.2968 55.0607 28.0297 21.6147 2.31% 2.49% 3.21%
Bega Cheese Limited (BGA) $1,902M -3.8555 0.1867 0.2091 27.1260 22.8592 18.9058 2.33% 2.73% 3.38%
Cobram Estate Olives Limited (CBO) $1,312M -0.7456 0.0000 0.0000 94.8097 0.0000 0.0000 1.64% 0.00% 0.00%
Nuchev Limited (NUC) $13M 0.2724 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Ricegrowers Limited (SGLLV) $970M -0.0114 -0.2480 0.1948 13.6816 18.1948 15.2283 5.00% 5.00% 5.00%

NUC Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 2.12 0.00
Market 0.30 13.20 1.03 0.74
Sector 0.41 14.70 0.87 0.89

NUC Directors

Name Position Start Date
Mr Ben McFarlane Dingle Non-Executive Chairman, Non-Executive Director 9 Apr 2013
Ms Elizabeth Smith (Liz) Non-Executive Director 29 Jul 2024
Mr Craig Silbery Non-Executive Director 16 Oct 2023
Mr Meng (Leo) Zhang Non-Executive Director 26 May 2025

Nuchev Limited (NUC) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
4 Dec 2025 ZHANG, Meng (Leo) Issued Related Securities 385,454 $0.174 $67,033.500
31 Oct 2025 SMITH (LIZ), Elizabeth Issued Related Securities 212,267 $0.174 $36,915.200
31 Oct 2025 SILBERY, Craig Issued Related Securities 350,990 $0.174 $61,040.000

See all changes in directors' interest & trades for Nuchev Limited (NUC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

NUC Management

Name Position
Matthew Parker CFO
Tamara Barr Company Secretary

NUC Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Nuchev Limited (NUC). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
75,567,031 (48.19%) H&S Investment Australia Pty Ltd
37,853,680 (24.14%) Ben McFarlane Dingle
12,564,873 (8.01%) Mithaq Capital

NUC Calendar of Events

Date Event
26 August 2027 Report (Annual)
26 August 2027 Report (Prelim)
23 February 2027 Report (Interim)
23 November 2026 AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.